What about cardiovascular toxicities of immune checkpoint inhibitors?

Eur J Hosp Pharm. 2021 Jan;28(1):2-3. doi: 10.1136/ejhpharm-2020-002277. Epub 2020 Apr 23.

Authors

Raquel Moreno Diaz¹, Mario Cazalla Garcia², Maria Pilar Bautista Sanz², Rosa Gonzalez Davia³, Adriana Carolina Rosero Rodriguez⁴

Affiliations

¹ Pharmacy Department, Hospital Universitario Infanta Cristina, Parla, Spain rmorenod@salud.madrid.org.
² Pharmacy Department, Hospital Universitario Infanta Cristina, Parla, Spain.
³ Cardiology, Hospital Universitario Infanta Cristina, Parla, Spain.
⁴ Oncology, Hospital Universitario Infanta Cristina, Parla, Spain.

No abstract available

Keywords: cardiology; chemotherapy; hospital pharmacy competencies; side effects of drugs; therapeutic drug monitoring.

Publication types

Editorial

MeSH terms

Humans
Immune Checkpoint Inhibitors*
Neoplasms* / drug therapy

Substances

Immune Checkpoint Inhibitors